According to recent research, BLM levels are elevated in a variety of cancers, including lung squamous cell carcinoma, colon adenocarcinoma, endometrial carcinoma, cervical squamous cell carcinoma, and endocervical adenocarcinoma [31,32]. This evidence concerns the gene BLM and squamous cell lung carcinoma.